ChartMill assigns a Buy % Consensus number of 84% to NRXP. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-15 | BTIG | Reiterate | Buy -> Buy |
| 2026-01-05 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-01-02 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-12-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-12-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-12-03 | BTIG | Reiterate | Buy -> Buy |
| 2025-12-02 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-17 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-10 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-30 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-10-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-10-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-29 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-08 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-22 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-19 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-11 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-04 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-23 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-20 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-06 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-16 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-30 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-29 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-04-02 | BTIG | Initiate | Buy |
| 2025-03-31 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-24 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-20 | D. Boral Capital | Maintains | Buy -> Buy |
10 analysts have analysed NRXP and the average price target is 37.49 USD. This implies a price increase of 1551.32% is expected in the next year compared to the current price of 2.27.
The consensus rating for NRX THERAPEUTICS INC (NRXP) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering NRX THERAPEUTICS INC (NRXP) is 10.